Fulgent Genetics Inc
NASDAQ:FLGT
Fulgent Genetics Inc
NASDAQ:FLGT
Price:
20.58 USD
2.39%
Market Closed
Updated:
Apr 30, 2024
Fulgent Genetics Inc
Cash from Operating Activities
|
Fulgent Genetics Inc
Cash from Operating Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Cash from Operating Activities
$27m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Operating Activities
$1.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Operating Activities
$13.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Operating Activities
$11.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Operating Activities
$1.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
See Also
What is Fulgent Genetics Inc's Cash from Operating Activities?
Cash from Operating Activities
27m
USD
27m
USD
Based on the financial report for Dec 31, 2023, Fulgent Genetics Inc's Cash from Operating Activities amounts to 27m USD.
What is Fulgent Genetics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-42%
-42%
Over the last year, the Cash from Operating Activities growth was -89%. The average annual Cash from Operating Activities growth rates for Fulgent Genetics Inc have been -42% over the past three years .
You don't have any saved screeners yet
